UK markets open in 7 hours 58 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.15 +0.20 (+0.25%) GOLD FUTURES
2,313.20 +3.60 (+0.16%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,320.98 +1,231.34 (+2.67%)
China Shineway Pharmaceutical Group Limited (2877.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 7.73B |
| Enterprise value | 1.68B |
| Trailing P/E | 6.76 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.45 |
| Price/book (mrq) | 1.02 |
| Enterprise value/revenue | 0.37 |
| Enterprise value/EBITDA | 1.18 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.81 |
| 52-week change 3 | 5.23% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 10.720 |
| 52-week low 3 | 6.550 |
| 50-day moving average 3 | 9.491 |
| 200-day moving average 3 | 7.976 |
Share statistics
| Avg vol (3-month) 3 | 780.44k |
| Avg vol (10-day) 3 | 624.6k |
| Shares outstanding 5 | 827M |
| Implied shares outstanding 6 | 827M |
| Float 8 | 207.04M |
| % held by insiders 1 | 66.31% |
| % held by institutions 1 | 4.96% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.58 |
| Forward annual dividend yield 4 | 6.25% |
| Trailing annual dividend rate 3 | 0.42 |
| Trailing annual dividend yield 3 | 4.54% |
| 5-year average dividend yield 4 | 6.23 |
| Payout ratio 4 | 32.88% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 29 Apr 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 21.47% |
| Operating margin (ttm) | 18.14% |
Management effectiveness
| Return on assets (ttm) | 6.81% |
| Return on equity (ttm) | 14.45% |
Income statement
| Revenue (ttm) | 4.52B |
| Revenue per share (ttm) | 5.98 |
| Quarterly revenue growth (yoy) | -0.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.14B |
| Net income avi to common (ttm) | 969.51M |
| Diluted EPS (ttm) | 1.400 |
| Quarterly earnings growth (yoy) | 22.10% |
Balance sheet
| Total cash (mrq) | 5.91B |
| Total cash per share (mrq) | 7.83 |
| Total debt (mrq) | 301.33M |
| Total debt/equity (mrq) | 4.28% |
| Current ratio (mrq) | 3.35 |
| Book value per share (mrq) | 9.31 |
Cash flow statement
| Operating cash flow (ttm) | 932.64M |
| Levered free cash flow (ttm) | 601.34M |
© 2024 Yahoo. All rights reserved.